Electroanalytical overview: the determination of chlorpromazine

Robert D. Crapnell, Craig E. Banks
2025-12-15

SCID:  54.1/zs69ntdm
Chlorpromazine is a first-generation antipsychotic medication that has been widely used in clinical psychiatry, where it is primarily prescribed for the treatment of a broad range of psychiatric conditions. There is a recognised need for the measurement of chlorpromazine, for which laboratory-based analytical instrumentation currently provides reliable and routine methodologies. However, there is significant scope to develop in-the-field analytical techniques that are comparable in performance to traditional laboratory equipment. Electroanalysis presents a promising opportunity in this context. Electrochemical sensors offer high sensitivity and selectivity, deliver rapid and cost-effective results, and are compatible with portable instrumentation. These advantages make electroanalysis well-suited for on-site analysis, enabling real-time monitoring without the constraints of a centralised laboratory. In this chapter, we summarise the use of electroanalysis for the detection of chlorpromazine summarising the latest endeavours.
Publication Details
Publication Date
2025-12-15
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Robert D. Crapnell
Craig E. Banks
Explore More Research
Use the citation graph to discover related papers and expand your research horizons.
Click any node to explore
Download PDF
100%